Could a light helmet boost memory in early Alzheimer's?
NCT ID NCT06618807
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a safe, non-invasive light therapy device (Neuro RX Gamma) in 60 adults aged 50+ with mild cognitive impairment due to Alzheimer's. The treatment uses near-infrared light to stimulate brain areas linked to memory. Researchers will check if it improves thinking, daily function, and brain health markers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Michael's Hospital, Unity Health Toronto
RECRUITINGToronto, Ontario, M5B 1T8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.